Palantir's UK NHS Data Platform Costs Rise to £1.1 Billion as Expected Benefits Are Revised Down
N.R. Finch
A UK government report shows the lifetime cost of Palantir's NHS Federated Data Platform has risen to £1.1 billion while expected benefits fell to £808 million — costs now exceed projected returns for the first time, and two parliamentary committees want the contract terminated.
How much has this platform cost — and what is it expected to return?
Lifetime cost has risen to £1.1 billion; expected benefits dropped to £808 million, leaving a gap of roughly £200 million.
This means → for every £1 the government puts in, it expects to get back about £0.73. The project is underwater on paper.
Officials attribute the cost increase to "accelerated delivery at scale." The benefits cut reflects revised rollout plans, better data quality, and — critically — "a deeper understanding of product performance, usage and adoption rates."
Why can't the numbers be compared to previous years?
The report switched to "outturn prices" for the first time, intended to enable "accurate tracking of progress and impact."
In plain terms = the government changed the ruler, so old and new figures no longer sit on the same scale.
Labour MP Ben Coleman has demanded NHS publish historical lifetime-cost and benefit estimates so the public can tell how much of the shift is real and how much is just a change in accounting method. This reflects growing parliamentary distrust of the data itself.
What pressure are Parliament and regulators applying?
Two parliamentary committees have called for Palantir's NHS contract to be ended, citing "serious public distrust" and disputed effectiveness.
Health Committee chair Layla Moran said the latest figures "will only intensify" the urgency to sever ties with Palantir before the year-end contract renewal deadline.
The UK statistics regulator opened an investigation in June into NHS claims about the platform's impact — triggered after NHS England added a disclaimer to its own methodology page, conceding that key data could not prove effectiveness.
How are NHS and Palantir responding?
NHS England says the project remains within its approved budget and that rising costs reflect "strong demand" — "a clear vote of confidence."
Palantir points out the platform ranks in the top 20% of government project-delivery ratings — one of just 29 projects rated green out of 172.
This means → both sides are reading the same numbers optimistically, but Parliament and the regulator are clearly unconvinced.
What is the next decision point?
The contract includes a 2027 exit clause; whether the government renews at year-end is the nearest inflection point.
NHS England plans to revise how two core metrics are calculated next month — after internal staff flagged flaws in the underlying analysis.
In plain terms = if the metrics methodology changes and parliamentary pressure keeps building, the political cost of renewal rises with every passing month.
Content is for reference only, not financial advice.